HLN N Stock Overview
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Haleon plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£66.02 |
| 52 Week High | UK£66.02 |
| 52 Week Low | UK£66.02 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| HLN N | MX Personal Products | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how HLN N performed against the MX Personal Products industry.
Return vs Market: Insufficient data to determine how HLN N performed against the MX Market.
Price Volatility
| HLN N volatility | |
|---|---|
| HLN N Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: HLN N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HLN N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1715 | 24,622 | Brian McNamara | www.haleon.com |
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum.
Haleon plc Fundamentals Summary
| HLN N fundamental statistics | |
|---|---|
| Market cap | Mex$730.28b |
| Earnings (TTM) | Mex$23.87b |
| Revenue (TTM) | Mex$244.49b |
30.6x
P/E Ratio3.0x
P/S RatioIs HLN N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HLN N income statement (TTM) | |
|---|---|
| Revenue | UK£10.86b |
| Cost of Revenue | UK£4.13b |
| Gross Profit | UK£6.73b |
| Other Expenses | UK£5.67b |
| Earnings | UK£1.06b |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Aug 02, 2023
| Earnings per share (EPS) | 0.11 |
| Gross Margin | 61.97% |
| Net Profit Margin | 9.76% |
| Debt/Equity Ratio | 63.5% |
How did HLN N perform over the long term?
See historical performance and comparison